Dasatinib-associated chylothorax in a pediatric patient with chronic myeloid leukemia: a case report and literature review

BACKGROUND: Dasatinib is an effective 2(nd) generation tyrosine kinase inhibitor for the treatment of newly diagnosed or intolerant to imatinib chronic myeloid leukemia (CML), and in Philadelphia chromosome (Ph)-positive acute lymphoblastic leukemia (ALL). The most common adverse effects of dasatini...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Qinqin, Fu, Jinqiu, Zhang, Aijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906050/
https://www.ncbi.nlm.nih.gov/pubmed/36760377
http://dx.doi.org/10.21037/tcr-22-1983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906050/
https://www.ncbi.nlm.nih.gov/pubmed/36760377
http://dx.doi.org/10.21037/tcr-22-1983

Ejemplares similares